October 2010 Archives by date

• Messages sorted by: [ thread ] [ subject ] [ author ]
• More info on this list...

Starting: Fri Oct 1 04:06:28 EDT 2010
Ending: Sun Oct 31 05:19:59 EDT 2010
Messages: 140

• [Ip-health] FT: US research funder licenses HIV patent   Thiru Balasubramaniam
• [Ip-health] Flynn Comments to India CL   Sean Flynn
• [Ip-health] White House Blog: US Government First to Share Patents with Medicines Patent Pool   Thiru Balasubramaniam
• [Ip-health] Medicines Patent Pool Foundation (MPPF)   Esther Tallah
• [Ip-health] Unitaid et le National Institute of Health americain annoncent le premier accord de licence pharmaceutique / UNITAD and NIH announce their first pharmaceutical license agreement   UNITAID Communication
• [Ip-health] FDA Warns Certain Gout-Drug Makers to Stop, And Soon   Joana Ramos
• [Ip-health] Comment on CL by Thai CSOs   Kar K.
• [Ip-health] Call for International Week of Action against EU-India FTA   prathibha siva
• [Ip-health] News: Bridges Weekly Trade News - EU-India FTA Talks Progress; Study Warns About Access to AIDS Drugs   Terri - Louise Beswick
• [Ip-health] TWN Info: WIPO: Assemblies Discuss Critical Substantive Issues   Sangeeta
• [Ip-health] TWN Info: Assemblies Hear Calls for More Member-State Oversight   Sangeeta
• [Ip-health] TWN Info: Assemblies Hear Calls for More Member-State Oversight   Sangeeta
• [Ip-health] TWN Info: WIPO: Assemblies Discuss Critical Substantive Issues   Sangeeta
• [Ip-health] News: PharmaTimes- France seeks 860m euros savings on drugs, devices in 2011   Terri - Louise Beswick
• [Ip-health] USTR briefing on ACTA/This Thursday   Judit Rius Sanjuan
• [Ip-health] IP Watch: ACTA: No More Negotiating Rounds Planned; Latest Text To Be Released   Judit Rius Sanjuan
• [Ip-health] Commission's response to MEPs on the lack of safeguards in ACTA and access to medicines   Malini Aisola
• [Ip-health] MEP questions Council and Commission on legal basis of negotiating ACTA   Malini Aisola
• [Ip-health] TWN Info: WIPO: Charges of Improper Practices, Cronyism Levelled at Top-Level Staff   Sangeeta
• [Ip-health] NY Times: National Institutes of Health Licenses Its Patent on a New Drug for AIDS   UNITAID Communication
• [Ip-health] Medicines Patent Pool Vacancy: Executive Assistant   Recruitment
• [Ip-health] Medicines Patent Pool Vacancy: Business Development Director   Recruitment
• [Ip-health] Recent U.S. legislation on Innovation in Energy and Agricultural sectors, dealing with prizes and patents.   James Love
• [Ip-health] 'DIE IN' PROTEST AGAINST THE EU-INDIA FTA NEGOTIATIONS BY DELHI BETWORK OF POSITIVE PEOPLE   Leena Menghaney
• [Ip-health] New York Times: Global Fight Against AIDS Falters as Pledges Fail to Reach Goal of $13 Billion   Thiru Balasubramaniam
• [Ip-health] UNITAID STATEMENT ON GLOBAL FUND REPLENISHMENT OUTCOME   UNITAID Communication
• [Ip-health] The October 2, 2010 version of the ACTA text   Jamie Love
• [Ip-health] Book on ex-post liability rules in modern patent law   Rosa Castro
• [Ip-health] Notes on released ACTA text   Sean Flynn
• [Ip-health] IGFAM - Tiered Pricing Discussion Paper - Not Protectively Marked   Charles Clift
• [Ip-health] Bridges Weekly: Anti-Counterfeiting Trade Pact ‘99 Percent’ Complete   Thiru Balasubramaniam
• [Ip-health] Bridges Weekly: Medicines Patent Pool Receives License, Backing from US Government   Thiru Balasubramaniam
• [Ip-health] HANDS OFF our medicines! MSF launches new campaign to stop Europe shutting the door on generic medicines   Michelle.VILK at geneva.msf.org
• [Ip-health] News: Guardian (UK)- Cancer fund will put £50m towards access to drugs   Terri - Louise Beswick
• [Ip-health] Novartis job ad for Director of Market Access, Latin America   Joana Ramos
• [Ip-health] IGFAM - Tiered Pricing Discussion Paper - Not Protectively Marked   James Love
• [Ip-health] HIV+ people lead protests against India-EU negotiations on free trade agreement   Kajal Bhardwaj
• [Ip-health] DNP+ FTA Protest Video   Kajal Bhardwaj
• [Ip-health] Urgent call for action: EU-india FTA protest | Police lathi charge DNP+ members   Kajal Bhardwaj
• [Ip-health] Ethical Pathway Act of 2010 – S. 3921   Judit Rius Sanjuan
• [Ip-health] Guardian: MSF launches attack on European Commission for blocking cheap drugs   Katy.ATHERSUCH at geneva.msf.org
• [Ip-health] Is Indian registration required for Indian export of medicines   Baker, Brook
• [Ip-health] Senator Wyden asks for legal review of ACTA from Congressional Research Service   James Love
• [Ip-health] SAVE THE DATE: Roundtable of the EPWG "Improving Health through Innovation and Access: What can the EU do now to make its commitments real?" European Parliament 27th October 12, 30 - 14, 30   Katy.ATHERSUCH at geneva.msf.org
• [Ip-health] Areas where the Oct 2, 2010 ACTA text is inconsistent with U.S. law   James Love
• [Ip-health] KEI roundtable on ACTA   Judit Rius Sanjuan
• [Ip-health] KEI general statement to the 15th Standing Committee on the Law of Patents (SCP)   Thiru Balasubramaniam
• [Ip-health] Global Food Assistance and the Fight Against Childhood Malnutrition   Judit Rius Sanjuan
• [Ip-health] MSF Access Campaign Vacancy: Medical Advisor – Tuberculosis and Antibiotic Resistance   Michelle.VILK at geneva.msf.org
• [Ip-health] Conference: Can we afford the Current Model of Innovation? November 18th in Brussels.   Sophie Bloemen
• [Ip-health] MSF Vacancy: MSF Access & Innovation Officer (South Africa)   Michelle.VILK at geneva.msf.org
• [Ip-health] Letter to European Commission in Nepal from National Association of People Living with HIV in Nepal   prathibha siva
• [Ip-health] Letter to the PM : Don’t sign on to intellectual property provisions in the India-EU FTA   prathibha siva
• [Ip-health] PRESS RELEASE : JOIN THE PROTEST INFRONT OF EU AND INDIAN MISSION AT 13TH OCT 2010, 1 PM   prathibha siva
• [Ip-health] OCT 28: Public Consultation on Trade, Access to Medicines, and the Right to Health with the U.N. Special Rapporteur on the Right to Health   Michael Palmedo
• [Ip-health] Group B proposal on Future Work for the WIPO Standing Committee on the Law of Patents   Thiru Balasubramaniam
• [Ip-health] KEI statement on Exclusions from Patentable Subject Matter and Exceptions and Limitations to the Rights   Thiru Balasubramaniam
• [Ip-health] KEI statement on Exclusions from Patentable Subject Matter and Exceptions and Limitations to the Rights   david at davidhammerstein.org
• [Ip-health] Laboratórios tentam impedir que 20 medicamentos tenham patentes liberadas   Joana Ramos
• [Ip-health] Job vacancy with MMV   Franziska Karyabwite
• [Ip-health] proposal from group B at SCP and a few updates on the session   Joana Varon
• [Ip-health] SCP 15: State of Play on day four of WIPO's patent committee   Thiru Balasubramaniam
• [Ip-health] Intellectual Property Watch: WIPO Members Search For A Negotiating Agenda On Patent Law   Thiru Balasubramaniam
• [Ip-health] The Hindu Business Line: India has mounted pressure on East African countries against the latter's proposed anti-counterfeiting legislation.   Ann-Marie Sevcsik
• [Ip-health] High Technology Entrepreneurs and the Patent System: Results of the 2008 Berkeley Patent Survey   Thiru Balasubramaniam
• [Ip-health] Chair presents proposal for future work to be discussed today, last day of SCP sessions   Joana Varon
• [Ip-health] Innovation but slow uptake of improved pediatric ARV formulations   Waning, Brenda
• [Ip-health] OFT fines Reckitt £10m for Gaviscon market abuse   Riaz K Tayob
• [Ip-health] AFP: WHO seeks "complete control" of tropical diseases   thiru at keionline.org
• [Ip-health] European Parliament will debate ACTA on Wednesday   Ante
• [Ip-health] Robert Naiman in the Huffington Post: Brazil Should Lead on Access to Essential Medicines   thiru at keionline.org
• [Ip-health] ACTA roundtable cancelled   Judit Rius Sanjuan
• [Ip-health] WIPO: Exclusions, Exceptions and Limitations Dominate Patents Talks   Sangeeta
• [Ip-health] Swiss IP office and Swiss Federal Office of Public Health: The Medicines Patent Pool - a new initiative to help increasing access to medicines for the developing world   Thiru Balasubramaniam
• [Ip-health] TR : Un ouvrage pour comprendre les rouages juridiques de la pharmaceutique // A new publication on research and development for neglected diseases   KRAUS Daniel
• [Ip-health] Restructuring at the World Health Organization   thiru at keionline.org
• [Ip-health] Senators Sanders and Brown write to Kappos at USPTO, ask if ACTA is consistent with US law   James Love
• [Ip-health] TWN Info: SCP agrees on future work, new issues on the agenda   Sangeeta
• [Ip-health] Intellectual Property Watch: WHO Moves IP, Innovation Out Of Director General’s Office   Thiru Balasubramaniam
• [Ip-health] SCP 15: Statement of the International Chamber of Commerce on exceptions and limitations   Thiru Balasubramaniam
• [Ip-health] Innovation but slow uptake of improved pediatric ARVformulations   Elodie Jambert
• [Ip-health] Activists fear deal will hurt Aids care   Kar K.
• [Ip-health] Bridges Weekly: WIPO Patent Committee Agrees on Issues for Future Work   Thiru Balasubramaniam
• [Ip-health] Intellectual Property Watch: Minister: India Anticipates European Fix To Law Delaying Generics Shipments   thiru at keionline.org
• [Ip-health] Hindu: India-EU FTA unlikely by December   Thiru Balasubramaniam
• [Ip-health] Pharmalot: More Senators Skeptical Over Counterfeit Trade Deal   Judit Rius Sanjuan
• [Ip-health] US drug lobby to meet key Indian govt officials this week   robert weissman
• [Ip-health] Low-cost cervical cancer vaccine, developed by UCCC researchers, moves to human trials   Joana Ramos
• [Ip-health] New ICTSD study: An International Legal Framework for the Sharing of Pathogens by F.Abbott   Ahmed Abdel Latif
• [Ip-health] Sanders, Brown Request Patent Office Assessment Of ACTA   James Love
• [Ip-health] USTR's implausible claim that ACTA Article 1.2 is an all purpose loophole, and the ramifications if true   James Love
• [Ip-health] Canada: "System for sending AIDS medication overseas needs overhaul: advocates" (National Post, Oct 23, 2010)   Richard Elliott
• [Ip-health] ACTA goes beyond present EU laws   Ante
• [Ip-health] Letter to the European Parliament regarding ACTA   James Love
• [Ip-health] Financial Times: Drugs groups diversify away from patents   Thiru Balasubramaniam
• [Ip-health] Françoise Castex Priority Written Question on ACTA   James Love
• [Ip-health] The New Democrats: The Coalition Pharma and Wall Street Love   robert weissman
• [Ip-health] EP question tabled on access to medicine and ACTA by MEP Michelle Rivasi   david at davidhammerstein.org
• [Ip-health] MEP Michèle Rivasi asks question about ACTA and Access to Medicine   James Love
• [Ip-health] UN Special Rap. Session: Access to Medicines & US Trade Policy   Matthew Kavanagh
• [Ip-health] question on EMA and follow on biologics   Vaughan, William
• [Ip-health] National Research Council Advises Universities to Improve Technology Transfer Offices   Krista Cox
• [Ip-health] "Access-to-medicine bill gets grim prognosis" (Globe & Mail, Oct 26, 2010)   Richard Elliott
• [Ip-health] Fixing Canada's Access to Medicines Regime: Open Letter to WTO Members re review of Doha Paragraph 6 Mechanism on Access to Medicines (October 27, 2010)   Richard Elliott
• [Ip-health] Open Letter to Indian Prime Minister on Takeover of Indian Drug Companies by MNcs   amit sen
• [Ip-health] Drug quality problems for GSK and BMS   Pierre Chirac
• [Ip-health] "IP and Climate Change"   jérôme de meeus
• [Ip-health] Drug quality problems for GSK and BMS   Baker, Brook
• [Ip-health] USTR positions in China WTO TRIPS dispute at odds with talking points on ACTA flexibility   James Love
• [Ip-health] Fixing Canada's Access to Medicines Regime: Open Letter to WTO Members re review of Doha Paragraph 6 Mechanism on Access to Medicines (October 27, 2010)   Ken Shadlen
• [Ip-health] Law Profs ask for Halt of ACTA   Sean Flynn
• [Ip-health] The Center for Global Health R&D Policy Assessment Seeks a Senior Program Officer   Ben Thomas
• [Ip-health] CORREC: UN Special Rapporteur Session on Access to Meds & Trade   Matthew Kavanagh
• [Ip-health] Drug quality problems for GSK and BMS   pierchir at club-internet.fr
• [Ip-health] Extracts of India's Intervention to the WTO TRIPS Council: ACTA   Thiru Balasubramaniam
• [Ip-health] News: Express Pharma- Fighting for flexbiblity   Marine Avrillon
• [Ip-health] News: Sourcejuice.com- The rapid development of India's pharmaceutical industry will take time quantum leap in yield potential   Marine Avrillon
• [Ip-health] News: Medical News Today- India's Trade Minister Says EU Will Take Steps To Prevent Seizure Of Generic Medicines   Marine Avrillon
• [Ip-health] Drug quality problems for GSK and BMS   Julian Harris
• [Ip-health] News: National Post- Trade deal would include increased protection for brand-name drugs   Marine Avrillon
• [Ip-health] MSF: Seven Years On, ?August 30 Decision? Has Failed to Improve Access to Medicines and Remains Virtually Unused   thiru at keionline.org
• [Ip-health] "Lifeline for patients in jeopardy" - Ottawa Citizen op-ed re CAMR (Oct 28, 2010)   Richard Elliott
• [Ip-health] News: Mondaq.com- Germany: Enhanced Patent System in Europe   Marine Avrillon
• [Ip-health] News: Bay Ledger News Zone- Eastern Europe confronts fake medicines trade   Marine Avrillon
• [Ip-health] News: Reuters- India sees generic drugs row with EU being settled   Marine Avrillon
• [Ip-health] News: Financial Express- Strong IPR rules must to bring funds: Big Pharma   Marine Avrillon
• [Ip-health] News: Medical News Today- PhRMA Representatives Meet With Officials In India To Discuss Compulsory Licensing   Marine Avrillon
• [Ip-health] Phrma's Assault on Health and Life   George Carter
• [Ip-health] News: publicvalues.ca- Big Pharma trying to sway Europe trade negotiations to fatten profits - NUPGE   Marine Avrillon
• [Ip-health] Atwood, K'naan back affordable medicine for world's poor (Globe & Mail, Oct 28, 2010)   Richard Elliott
• [Ip-health] Brazilian intervention at TRIPS Council: ACTA   Thiru Balasubramaniam
• [Ip-health] Consultation with Anand Grover   Sean Flynn
• [Ip-health] ACTA: Week in review   Sean Flynn
• [Ip-health] Drug quality problems for GSK and BMS   Baker, Brook
• [Ip-health] Inside U.S. Trade: U.S. Patent Office Unsure If ACTA Conflicts With Health Care Reform   Judit Rius Sanjuan
• [Ip-health] Brazil Superior Court denies extension of Novartis Glivec/Gleevec patent   Joana Ramos
• [Ip-health] U.S. Says Genes Should Not Be Eligible for Patents   Joana Ramos
• [Ip-health] US Gov´t brief: "genes from humans or nature should not be patented". Possible important policy shift.   david at davidhammerstein.org
• [Ip-health] Canada's Intervention to TRIPS Council: Experience using the System (Apotex-Rwanda Case)   Thiru Balasubramaniam
• [Ip-health] IP-Watch: TRIPS Council Discusses Efficacy Of ACTA, Public Health Amendment   Thiru Balasubramaniam

Last message date: Sun Oct 31 05:19:59 EDT 2010
Archived on: Sun Oct 31 05:31:14 EDT 2010

• Messages sorted by: [ thread ] [ subject ] [ author ]
• More info on this list...